MENU
+Compare
MYND
Stock ticker: ASE
AS OF
Dec 24, 11:57 AM (EDT)
Price
$1.98
Change
+$0.13 (+7.03%)
Capitalization
206.78M

MYND Myndai Forecast, Technical & Fundamental Analysis

a provider of objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD)

MYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MYND with price predictions
Dec 23, 2024

MYND in upward trend: price may jump up because it broke its lower Bollinger Band on December 19, 2024

MYND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where MYND's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

MYND moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MYND advanced for three days, in of 205 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 79 cases where MYND Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MYND moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MYND as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MYND turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MYND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.661) is normal, around the industry mean (27.597). P/E Ratio (9.123) is within average values for comparable stocks, (88.791). MYND's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.729). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (0.497) is also within normal values, averaging (11.883).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
MYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a provider of objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD)

Industry MiscellaneousCommercialServices

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
3rd Floor, No. 28 Building
Phone
+86 1087675611
Employees
N/A
Web
https://www.mynd.ai
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCPSX79.331.18
+1.51%
ProFunds UltraSector Health Care Svc
TIERX7.760.07
+0.91%
Nuveen International Eq A
WELNX9.320.05
+0.54%
William Blair Emerging Mkts Ldrs N
RAGTX63.82N/A
N/A
Virtus Zevenbergen Technology A
LGOQX23.35-0.11
-0.47%
Lord Abbett Growth Opportunities R2

MYND and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MYND has been loosely correlated with BAER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MYND jumps, then BAER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYND
1D Price
Change %
MYND100%
-1.60%
BAER - MYND
48%
Loosely correlated
-2.24%
AERT - MYND
36%
Loosely correlated
-4.82%
SKIL - MYND
24%
Poorly correlated
-0.05%
ABM - MYND
23%
Poorly correlated
+0.02%
CRAI - MYND
21%
Poorly correlated
-0.57%
More